Science Evolution At FDA ‘Transformative,’ Advisors Say
This article was originally published in The Gray Sheet
Executive Summary
An FDA Science Board subcommittee report finds industry and researcher perceptions of FDA's science readiness has improved over the past eight years. But the agency still faces major challenges tied to the current speed of scientific and technical progress.